MIT: How Often Do Vaccine Trials Hit Paydirt?
May 28, 2020
May 28, 2020
CAMBRIDGE, Massachusetts, May 28 -- The Massachusetts Institute of Technology issued the following news:
Vaccines are more likely to get through clinical trials than any other type of drug -- but have been given relatively little pharmaceutical industry support during the last two decades, according to a new study by MIT scholars.
Over a two-decade span from January 2000 to January 2020, private-sector vaccine-development efforts succeeded in bringing a drug to market 3 . . .
Vaccines are more likely to get through clinical trials than any other type of drug -- but have been given relatively little pharmaceutical industry support during the last two decades, according to a new study by MIT scholars.
Over a two-decade span from January 2000 to January 2020, private-sector vaccine-development efforts succeeded in bringing a drug to market 3 . . .